Smyth, Mark J.
Ngiow, Shin Foong
Ribas, Antoni
Teng, Michele W. L.
Article History
First Online: 24 November 2015
Competing interests
: M.J.S. has a scientific research agreement with Bristol–Myers Squibb and Medimmune and is a consultant to Kymab, F-star and Amgen. A.R. has consulted for Amgen, Genentech-Roche, GSK, Merck and Pierre Fabre, with honoraria paid to his institution. A.R. is on the Scientific Advisory Boards of Compugen, Flexus Bio and Kite Pharma. The other authors declare no competing interests.